ArticlePhysics and imaging in radiation oncology2024
External validation of a multimodality deep-learning normal tissue complication probability model for mandibular osteoradionecrosis trained on 3D radiation distribution maps and clinical variables.
Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Personalized Prevention of Osteoradionecrosis of the Jaws: From Clinical Risk Profiling and Site-Specific Dosimetry to Artificial Intelligence and Individualized Treatment-Effect Estimation.Journal of personalized medicine · 2026Review
- Beyond the dose-volume histogram: a critical appraisal of normal tissue complication probability modelling for osteoradionecrosis of the jaw and a strategic framework for clinical translation.Frontiers in oncology · 2026Article
- Current status and future directions of multimodal deep learning normal tissue complication probability modelling in head and neck cancer radiotherapy.Frontiers in oncology · 2026Review
- Radiotherapy for primary bone tumors: current techniques and integration of artificial intelligence-a review.Frontiers in oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: While the inclusion of spatial dose information in deep learning (DL)-based normal-tissue complication probability (NTCP) models has been the focus of recent research studies, external validation is still lacking. This study aimed to externally validate a DL-based NTCP model for mandibular osteoradionecrosis (ORN) trained on 3D radiation dose distribution maps and clinical variables. Methods and materials: A 3D DenseNet-40 convolutional neural network (3D-mDN40) was trained on clinical and radiation dose distribution maps on a retrospective class-balanced matched cohort of 184 subjects. A second model (3D-DN40) was trained on dose maps only and both DL models were compared to a logistic regression (LR) model trained on DVH metrics and clinical variables. All models were externally validated by means of their discriminative ability and calibration on an independent dataset of 82 subjects. Results: No significant difference in performance was observed between models. In internal validation, these exhibited similar Brier scores around 0.2, Log Loss values of 0.6-0.7 and ROC AUC values around 0.7 (internal) and 0.6 (external). Differences in clinical variable distributions and their effect sizes were observed between internal and external cohorts, such as smoking status (0.6 vs. 0.1) and chemotherapy (0.1 vs. -0.5), respectively. Conclusion: To our knowledge, this is the first study to externally validate a multimodality DL-based ORN NTCP model. Utilising mandible dose distribution maps, these models show promise for enhancing spatial risk assessment and guiding dental and oncological decision-making, though further research is essential to address overfitting and domain shift for reliable clinical use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.